idecabtagene vicleucel (Pending FDA Approval)

Brand and Other Names:

Classes: CAR-T Cell Therapies

Share
Email
Print
Feedback

Sections

Sections idecabtagene vicleucel
Dosing & Uses
Pharmacology
Images
Patient Handout

Dosing & Uses

Multiple Myeloma

Pending FDA approval for multiple myeloma

Mechanism of Action

B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy

Images

Patient Handout

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]

Sections idecabtagene vicleucel
Dosing & Uses
Pharmacology
Images
Patient Handout

idecabtagene vicleucel (Pending FDA Approval)

Dosing & Uses

Multiple Myeloma

Pharmacology

Mechanism of Action

Images

Patient Handout

About

Membership

Apps

WebMD Network

Editions

idecabtagene vicleucel (Pending FDA Approval)

Dosing & Uses

Multiple Myeloma

Pharmacology

Mechanism of Action

Images

Patient Handout

What would you like to print?

Dosing Calculator

Find Us On

About

Membership

Apps

WebMD Network

Editions